Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000646079 | SCV000767836 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2017-12-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190906 | SCV001358541 | likely benign | Cardiomyopathy | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613422 | SCV001839076 | likely benign | not provided | 2019-03-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002424483 | SCV002679335 | likely benign | Cardiovascular phenotype | 2020-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003451543 | SCV004180502 | likely benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451544 | SCV004180503 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451542 | SCV004180504 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing |